121 related articles for article (PubMed ID: 15575032)
1. Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms.
Aiello EJ; Buist DS; White E; Seger D; Taplin SH
J Am Board Fam Pract; 2004; 17(6):408-15. PubMed ID: 15575032
[TBL] [Abstract][Full Text] [Related]
2. Self-reported symptoms among participants in a population-based screening program.
Larsen M; Lilleborge M; Vigeland E; Hofvind S
Breast; 2020 Dec; 54():56-61. PubMed ID: 32927237
[TBL] [Abstract][Full Text] [Related]
3. Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program.
Ryerson AB; Miller J; Eheman CR
Cancer Causes Control; 2015 May; 26(5):733-40. PubMed ID: 25754109
[TBL] [Abstract][Full Text] [Related]
4. The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status.
Kavanagh AM; Giles GG; Mitchell H; Cawson JN
J Med Screen; 2000; 7(2):105-10. PubMed ID: 11002452
[TBL] [Abstract][Full Text] [Related]
5. Performance of diagnostic mammography for women with signs or symptoms of breast cancer.
Barlow WE; Lehman CD; Zheng Y; Ballard-Barbash R; Yankaskas BC; Cutter GR; Carney PA; Geller BM; Rosenberg R; Kerlikowske K; Weaver DL; Taplin SH
J Natl Cancer Inst; 2002 Aug; 94(15):1151-9. PubMed ID: 12165640
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
[TBL] [Abstract][Full Text] [Related]
7. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis.
Singh D; Malila N; Pitkäniemi J; Anttila A
Int J Cancer; 2019 Jun; 144(12):2928-2935. PubMed ID: 30511466
[TBL] [Abstract][Full Text] [Related]
9. The relevance of reported symptoms in a breast screening programme.
Williams RS; Brook D; Monypenny IJ; Gower-Thomas K
Clin Radiol; 2002 Aug; 57(8):725-9. PubMed ID: 12169283
[TBL] [Abstract][Full Text] [Related]
10. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
[TBL] [Abstract][Full Text] [Related]
11. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
12. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.
White A; Miller J; Royalty J; Ryerson AB; Benard V; Helsel W; Kammerer W
Cancer Causes Control; 2015 May; 26(5):723-32. PubMed ID: 25809209
[TBL] [Abstract][Full Text] [Related]
14. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
May DS; Lee NC; Nadel MR; Henson RM; Miller DS
AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with imaging and procedural events used to detect breast cancer after screening mammography.
Carney PA; Abraham LA; Miglioretti DL; Yabroff KR; Sickles EA; Buist DS; Kasales CJ; Geller BM; Rosenberg RD; Dignan MB; Weaver DL; Kerlikowske K;
AJR Am J Roentgenol; 2007 Feb; 188(2):385-92. PubMed ID: 17242246
[TBL] [Abstract][Full Text] [Related]
16. Mammography performance in Oman: Review of factors influencing cancer yield and positive predictive value.
Taif S; Tufail F; Alnuaimi AS
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e250-8. PubMed ID: 24673798
[TBL] [Abstract][Full Text] [Related]
17. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
Burman ML; Taplin SH; Herta DF; Elmore JG
Ann Intern Med; 1999 Jul; 131(1):1-6. PubMed ID: 10391809
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
19. Association of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study.
Singh D; Miettinen J; Duffy S; Malila N; Pitkäniemi J; Anttila A
Br J Cancer; 2018 Nov; 119(11):1428-1435. PubMed ID: 30401890
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
